← Leaderboards
Andrei G. Vlassenko
Washington University
$6,750,146
Attributed
$13,500,291
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,500,291 · 6
By mechanism
R01$8,495,185 · 3
RF1$4,577,481 · 2
R21$427,625 · 1
Top collaborators
- Manu S Goyal8 shared
- Marcus E Raichle6 shared
- Cornelius Von Morze2 shared
Most similar at Washington University
Same institution · by research overlap
- Dwight A Towler$18,000,286
- Nathan Oliver Stitziel$30,076,422
- Sharon Cresci$7,282,232
- Brian N Finck$17,740,854
- John Morris$91,785,862
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCognitiveBrainAdultMetabolicPositron-Emission TomographyAerobic GlycolysisIn VivoMetabolismImpaired CognitionS DiseaseGlucoseOxygenBrain MetabolismInsightParticipantGlucose MetabolismBiological MarkersAreaPre-ClinicalCognitive TestingFunctional DisorderLearningAnabolism
Grant awards (16)
White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's Disease$705,859
R01 · FY2025 · AG · contact PI
Feasibility and reproducibility of hyperpolarized 13C pyruvate human brain imaging on a new MRI scanner platform$194,375
R21 · FY2025 · AG
Feasibility and reproducibility of hyperpolarized 13C pyruvate human brain imaging on a new MRI scanner platform$233,250
R21 · FY2024 · AG
Brain metabolism during task-evoked and spontaneous activity in aging and Alzheimer's disease$2,289,625
RF1 · FY2023 · AG · contact PI
White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's Disease$2,287,856
RF1 · FY2022 · AG · contact PI
Aerobic Glycolysis in the Development ofAlzheimer's Disease$728,926
R01 · FY2021 · AG · contact PI
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$690,801
R01 · FY2021 · AG · contact PI
Aerobic Glycolysis in the Development ofAlzheimer's Disease$737,891
R01 · FY2020 · AG · contact PI
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$731,109
R01 · FY2020 · AG · contact PI
Aerobic Glycolysis in the Development ofAlzheimer's Disease$746,358
R01 · FY2019 · AG · contact PI
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$745,594
R01 · FY2019 · AG · contact PI
Aerobic Glycolysis in the Development ofAlzheimer's Disease$381,228
R01 · FY2019 · AG · contact PI
Aerobic Glycolysis in the Development ofAlzheimer's Disease$754,355
R01 · FY2018 · AG · contact PI
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$752,185
R01 · FY2018 · AG · contact PI
Aerobic Glycolysis in the Development ofAlzheimer's Disease$762,198
R01 · FY2017 · AG · contact PI
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$758,681
R01 · FY2017 · AG · contact PI